Cell Therapy News/Articles, page-17012

Are you saying that all FDA-approved drugs treatments actually work on all patients?

What are you smoking?

The FDA not only approves drugs and treatments that don't work on all patients, they approve them when they cause damage to patients.


That's the reason for caution most of the time. Because with traditional pharmaceutical drugs, you can get side effects like Thalidomide.

They also regularly approve drugs and treatments which correlate with benefits to patients, in mechanisms they don't actually understand!!!

But for MSB's cell therapies they are exceeding all expectations. Not only do they change the goal posts constantly but they're suddenly fascinated by the precise operation of the treatment, they want to measure how it works. This, combined with the difficulty in obtaining suitable patients during the worst of the Covid19 epidemic (still not over btw), has unfairly hamstrung MSB. The FDA admit that MSB's therapies DO NOT HARM patients. We are just stuck with the FDA's sudden fascination with understanding the mechanism and measuring it..

But we have whytee calling out constantly, just do the trial, with no understanding of what actually has gone on, and is even going on now. At least the kiddies are splashing in the pool, that surely the constant, and must be why the concentration span is so short.